FORA Capital, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1742435 MIAMI, FL

Position in VRTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,133,537

-$107,178 QoQ

Shares Held

2,282

-28.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#812

of 1,735 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FORA Capital, LLC holds $19,737,715 across 20 Biotechnology names. VRTX ranks #10 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	5,209	$1,568,065
2	ABVX	Abivax S.A.	11,758	$1,566,871
3	ROIV	Roivant Sciences Ltd.	44,129	$1,561,725
4	AXSM	Axsome Therapeutics, Inc.	6,364	$1,557,716
5	TVTX	Travere Therapeutics, Inc.	27,289	$1,550,288
6	PRAX	Praxis Precision Medicines, Inc.	4,205	$1,407,791
7	REGN	Regeneron Pharmaceuticals, Inc.	2,147	$1,338,740
8	JAZZ	Jazz Pharmaceuticals plc	5,408	$1,303,165

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,133,537	2,282	-28.0%	Shares	Sole	2026-08-13
2025-09-30	$1,240,715	3,168	-66.3%	Shares	Sole	2025-11-13
2024-09-30	$4,372,682	9,402	+15.0%	Shares	Sole	2024-11-13
2024-06-30	$3,830,848	8,173	+68.7%	Shares	Sole	2024-08-13
2024-03-31	$2,024,840	4,844	-68.1%	Shares	Sole	2024-05-02
2023-09-30	$5,281,822	15,189	+286.3%	Shares	Sole	2023-11-13
2023-06-30	$1,383,710	3,932	-33.5%	Shares	Sole	2023-08-11
2021-12-31	$1,297,616	5,909	-0.3%	Shares	Sole	2022-02-11
2021-09-30	$1,074,917	5,926	+42.6%	Shares	Sole	2021-11-15
2021-03-31	$893,297	4,157	+11.1%	Shares	Sole	2021-05-17
2020-03-31	$890,170	3,741	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.